Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients

Clinical trial NCT04375956 · UNKNOWN

Trial details

NCT number: NCT04375956
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube Cancer

Start date: 2021-04-26
Primary completion: 2025-06-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.